课题基金 / 基金详情

The role of capicua in spinocerebellar ataxia type 1

The role of capicua in spinocerebellar ataxia type 1
Capicua 在 1 型脊髓小脑共济失调中的作用
批准号:
7450898
负责人:
John David Fryer
金额:
$5.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2009-05-31

项目摘要

项目成果

John David Fryer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this project is to determine the role of capicua (Cic) in spinocerebellar ataxia type 1 (SCA1), a neurodegenerative disease caused by a polyglutamine expansion in Ataxin-1 (Atx-1). Cic is a transcriptional represser in Drosophila and preliminary results show that Cic interacts with Atx-1, co-localizes to Purkinje neurons that degenerate in SCA1, and its level is reduced in Atx-1-null mice. I will first analyze the expression of Cic during development in wild-type and Atx-1-null mice. I will generate and characterize Cic- null mice (Cic-/-) to determine the normal role of Cic in vivo and to determine its role in the normal function of Atx-1 (when crossed to Atx-1-null mice). Cic-null mice will be crossed to a knock-in model of SCA1 to determine whether and how Cic affects SCA1 pathogenesis. Given Cic's role as a transcriptional represser, I will investigate gene expression changes by microarray analysis in Cic and Cic-/- mice. Changes in Cic mutants will be compared to those of Atx-1-null and SCA1 knock-in mice (currently being performed by other laboratory members) to pinpoint those changes most relevant to SCA1 and Atx-1 function. This project will establish the role of Cic in mammals and in the normal function of Atx-1 and in SCA1 pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel genetic modifiers of C9orf72 and Tau toxicity
  • 批准号:
    10084641
  • 项目类别:
  • 资助金额:
    $403.72万
  • 财政年份:
    2019
  • 负责人:
    John David Fryer
  • 依托单位:
Functions of human and mouse Trem2 in vivo
  • 批准号:
    9248837
  • 项目类别:
  • 资助金额:
    $19.56万
  • 财政年份:
    2016
  • 负责人:
    John David Fryer
  • 依托单位:
Development and characterization of a novel Clusterin mouse model
  • 批准号:
    9065478
  • 项目类别:
  • 资助金额:
    $7.83万
  • 财政年份:
    2015
  • 负责人:
    John David Fryer
  • 依托单位:
The role of Clusterin in cerebral amyloid angiopathy
  • 批准号:
    9765415
  • 项目类别:
  • 资助金额:
    $34.23万
  • 财政年份:
    2015
  • 负责人:
    John David Fryer
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: